Cargando…

A New Chemiluminescence Immunoassay for Phospholipase A(2) Receptor 1 Autoantibodies Allows Early Identification of Autoantibody Recurrence in Patients With Membranous Nephropathy

BACKGROUND: Circulating autoantibodies against the M-type phospholipase A(2) receptor 1 (PLA(2)R1) are important biomarkers in membranous nephropathy (MN), supporting the diagnosis and the clinical monitoring of patients. Standardized recombinant cell-based indirect immunofluorescence assay (RC-IFA)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hoxha, Elion, Stahl, Rolf A.K., Reinhard, Linda, Kühnl, Alexander, Schlumberger, Wolfgang, Dähnrich, Cornelia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071618/ https://www.ncbi.nlm.nih.gov/pubmed/33912742 http://dx.doi.org/10.1016/j.ekir.2020.12.034

Ejemplares similares

Development of a Standardized Chemiluminescence Immunoassay for the Detection of Autoantibodies Against Human M-Type Phospholipase A2 Receptor in Primary Membranous Nephropathy
por: Dähnrich, Cornelia, et al.
Publicado: (2019)

Serodiagnosis of Anti-glomerular Basement Membrane Disease Using a Newly Developed Chemiluminescence Immunoassay
por: Kühnl, Alexander, et al.
Publicado: (2022)

Chemiluminescent immunoassay technology: what does it change in autoantibody detection?
por: Cinquanta, Luigi, et al.
Publicado: (2017)

Membranous Nephropathy: The Journey Continues …
por: Hoxha, Elion, et al.
Publicado: (2015)

Autoantibodies against thyroid hormones and their influence on thyroxine determination with chemiluminescence immunoassay in dogs
por: Piechotta, Marion, et al.
Publicado: (2010)

Role of phospholipase A(2) receptor 1 antibody level at diagnosis for long-term renal outcome in membranous nephropathy
por: Mahmud, Maida, et al.
Publicado: (2019)

Detection of autoantibodies using chemiluminescence technologies
por: Mahler, Michael, et al.
Publicado: (2016)

A Genetic Risk Score Distinguishes Different Types of Autoantibody-Mediated Membranous Nephropathy
por: Gupta, Sanjana, et al.
Publicado: (2023)

Efficiency of a solid-phase chemiluminescence immunoassay for detection of antinuclear and cytoplasmic autoantibodies compared with gold standard immunoprecipitation
por: Gelpí, Carmen, et al.
Publicado: (2014)

Autoantibodies against Phospholipase A(2) Receptor in Korean Patients with Membranous Nephropathy
por: Oh, Yun Jung, et al.
Publicado: (2013)

The reliability of immunoassays to detect autoantibodies in patients with myositis is dependent on autoantibody specificity
por: Tansley, Sarah L, et al.
Publicado: (2020)

Development of a Recombinant Cell-Based Indirect Immunofluorescence Assay for the Determination of Autoantibodies against Soluble Liver Antigen in Autoimmune Hepatitis
por: Radzimski, Christiane, et al.
Publicado: (2013)

The utility of phospholipase A2 receptor autoantibody in membranous nephropathy after kidney transplantation
por: Xipell, Marc, et al.
Publicado: (2018)

Clinical evaluation of autoantibodies to a novel PM/Scl peptide antigen
por: Mahler, Michael, et al.
Publicado: (2005)

Clinical Comparison of QUANTA Flash dsDNA Chemiluminescent Immunoassay with Four Current Assays for the Detection of Anti-dsDNA Autoantibodies
por: Infantino, Maria, et al.
Publicado: (2015)

Anti-Phospholipase A(2) Receptor Autoantibody: A New Biomarker for Primary Membranous Nephropathy
por: Zhu, Quansheng
Publicado: (2016)

Effect of belimumab on proteinuria and anti-phospholipase A2 receptor autoantibody in primary membranous nephropathy
por: Barrett, Christine, et al.
Publicado: (2020)

Antigen-Specific IgG Subclasses in Primary and Malignancy-Associated Membranous Nephropathy
por: von Haxthausen, Franziska, et al.
Publicado: (2018)

The promise, perceptions, and pitfalls of immunoassays for autoantibody testing in myositis
por: Tansley, Sarah L., et al.
Publicado: (2020)

Phospholipase A2 Receptor Autoantibodies as a Novel Serological Biomarker for Autoimmune Thyroid Disease Associated Nephropathy
por: Huang, Biao, et al.
Publicado: (2020)

Autoantibodies in Renal Diseases – Clinical Significance and Recent Developments in Serological Detection
por: Mastroianni-Kirsztajn, Gianna, et al.
Publicado: (2015)

Antiphospholipase A(2) Receptor Autoantibodies: A Comparison of Three Different Immunoassays for the Diagnosis of Idiopathic Membranous Nephropathy
por: Behnert, Astrid, et al.
Publicado: (2014)

Autoantibodies in Myositis. How to Achieve a Comprehensive Strategy for Serological Testing
por: Mende, Miriam, et al.
Publicado: (2019)

Utility of Determining Autoantibodies to M-type Phospholipase A2 Receptor in Diagnosing Primary Membranous Nephropathy: An Ideal Setting
por: Ramachandran, R., et al.
Publicado: (2017)

Corrigendum: Autoantibodies in renal diseases – clinical significance and recent developments in serological detection
por: Mastroianni-Kirsztajn, Gianna, et al.
Publicado: (2020)

Autoantibodies in the Diagnosis, Monitoring, and Treatment of Membranous Nephropathy
por: Tesar, Vladimir, et al.
Publicado: (2021)

Autoantibodies to Cytosolic 5′-Nucleotidase 1A in Primary Sjögren’s Syndrome and Systemic Lupus Erythematosus
por: Rietveld, Anke, et al.
Publicado: (2018)

Characterization of THSD7A-antibodies not binding to glomerular THSD7A in a patient with diabetes mellitus but no membranous nephropathy
por: Reinhard, Linda, et al.
Publicado: (2021)

Development and evaluation of a standardized ELISA for the determination of autoantibodies against cN-1A (Mup44, NT5C1A) in sporadic inclusion body myositis
por: Kramp, Sabine L., et al.
Publicado: (2016)

The prognostic value of phospholipase A2 receptor autoantibodies on spontaneous remission for patients with idiopathic membranous nephropathy: A meta-analysis
por: Wu, Wenli, et al.
Publicado: (2018)

A Simple and Fast Non-Radioactive Bridging Immunoassay for Insulin Autoantibodies
por: Kikkas, Ingrid, et al.
Publicado: (2013)

Commentary: Comparison of different assays for the detection of anticyclic citrullinated peptide antibodies in patients with rheumatoid arthritis
por: Saschenbrecker, Sandra, et al.
Publicado: (2022)

Rpp25 is a major target of autoantibodies to the Th/To complex as measured by a novel chemiluminescent assay
por: Mahler, Michael, et al.
Publicado: (2013)

PLA(2)R Antibody Levels and Clinical Outcome in Patients with Membranous Nephropathy and Non-Nephrotic Range Proteinuria under Treatment with Inhibitors of the Renin-Angiotensin System
por: Hoxha, Elion, et al.
Publicado: (2014)

Perspectives in membranous nephropathy
por: Tomas, Nicola M., et al.
Publicado: (2021)

Comparison of different immunoassays detecting anti-chromatin autoantibodies in systemic lupus erythematosus (SLE)
por: Roux-Lombard, P, et al.
Publicado: (2002)

Evaluation of a new chemiluminescence immunoassay for diagnosis of syphilis
por: Mo, Xiaohui, et al.
Publicado: (2010)

Chemiluminescence based immunoassay for the detection of heroin and its metabolites
por: Singh, Smritee, et al.
Publicado: (2018)

Chemiluminescence Immunoassay to Detect Anti‐HTLV‐I Antibodies
por: Kamihira, Shimeru, et al.
Publicado: (1993)

Highly Specific Chemiluminescence Immunoassay for the Determination of Chloramphenicol in Cosmetics
por: Li, Qiyan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_d4vk0pl05i0me53pqdidgvqhjp